Risk for thrombosis linked to the target antigen of a lupus anticoagulant?
Arnout
J
J
Center for Molecular and Vascular Biology, University of Leuven, Leuven Belgium, Campus Gasthuisberg, Leuven, Belgium. jef.arnout@med.kuleuven.ac.be
D000936:Antigen-Antibody Complex; D001324:Autoantigens / Q000276:immunology* / Q000502:physiology; D006023:Glycoproteins / Q000276:immunology / Q000502:physiology; D006801:Humans; D016682:Lupus Coagulation Inhibitor / Q000276:immunology* / Q000502:physiology; D011516:Prothrombin / Q000276:immunology / Q000502:physiology; D012306:Risk; D013927:Thrombosis / Q000209:etiology* / Q000276:immunology; D053482:beta 2-Glycoprotein I
D000936:Antigen-Antibody Complex; D001324:Autoantigens; D006023:Glycoproteins; D016682:Lupus Coagulation Inhibitor; D053482:beta 2-Glycoprotein I; D011516:Prothrombin